LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

LLY

1,077

-2.36%↓

JNJ

223.52

-0.74%↓

ABBV

212.36

-2.57%↓

UNH

379.41

+0.2%↑

MRK

114.99

-3.04%↓

Home・Aktien・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Geschlossen

BrancheGesundheitswesen

21.45

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.6M -21M
Verkäufe	14M 54M
Gewinnspanne	-39.611
Angestellte	178
EBITDA	-7.7M -26M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-3.62% downside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	1B 2.2B
Vorheriger Eröffnungskurs	21.45
Vorheriger Schlusskurs	21.45

Nachrichtenstimmung

By Acuity

50%

153 / 344 Ranking in Healthcare

Day One Biopharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Juni 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Optimism Over AI Demand -- Market Talk

1. Juni 2026, 23:38 UTC

Akquisitionen, Fusionen, Übernahmen

Google Seeks $80 Billion for AI Buildout; Berkshire Will Buy $10 Billion Stake -- WSJ

1. Juni 2026, 23:37 UTC

Market Talk

Oil Edges Higher; Trump Seeks to Quell Israel-Hezbollah Conflict -- Market Talk

1. Juni 2026, 23:01 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1. Juni 2026, 23:01 UTC

Market Talk

Dexus Stuck in 'Too Hard' Basket -- Market Talk

1. Juni 2026, 22:08 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Issue $80 Billion of Equity for AI Buildout. Berkshire to Buy $10 Billion. -- Barrons.com

1. Juni 2026, 22:01 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Issue $80 Billion of Equity for AI Buildout. Berkshire to Buy $10 Billion. -- Barrons.com

1. Juni 2026, 22:01 UTC

Akquisitionen, Fusionen, Übernahmen

Google Seeks to Raise $80 Billion for AI Infrastructure -- Update

1. Juni 2026, 21:55 UTC

Akquisitionen, Fusionen, Übernahmen

Greg Abel's Week Is Off to Quite a Start -- WSJ

1. Juni 2026, 21:53 UTC

Market Talk

Strong Earnings Suppress Concerns About Oil Market -- Market Talk

1. Juni 2026, 21:22 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Berkshire's Abel Takes Big Swing With Back-to-Back Deals -- Market Talk

1. Juni 2026, 20:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

1. Juni 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1. Juni 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

1. Juni 2026, 20:46 UTC

Akquisitionen, Fusionen, Übernahmen

The Odds SpaceX Merges With Tesla Are Higher Than You Think -- Barrons.com

1. Juni 2026, 20:22 UTC

Akquisitionen, Fusionen, Übernahmen

Array Digital Infrastructure Doesn't Expect Additional Divs in 2026

1. Juni 2026, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Array Digital Infrastructure Div Payable June 25 to Hldrs of Record June 11

1. Juni 2026, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Array Digital Infrastructure Declares $11 Special Div

1. Juni 2026, 20:20 UTC

Akquisitionen, Fusionen, Übernahmen

Array Completes Sale of Select Spectrum Assets to Verizon for $1B

1. Juni 2026, 19:40 UTC

Market Talk

Remittances to Mexico Rise for Third Straight Month -- Market Talk

1. Juni 2026, 19:28 UTC

Market Talk

BoC Official Reiterates Need to Improve Business Investment -- Market Talk

1. Juni 2026, 19:01 UTC

Market Talk

Oil Futures Rise On Concerns About U.S.-Iran Talks -- Market Talk

1. Juni 2026, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Snap 3-Session Winning Streak -- Market Talk

1. Juni 2026, 18:54 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire Stock Drops. Its Bargain-Priced Deal for Home Builder Fails to Impress Investors. -- Barrons.com

1. Juni 2026, 18:33 UTC

Market Talk

Mexican PMIs Show Sluggish Manufacturing in May -- Market Talk

1. Juni 2026, 18:32 UTC

Market Talk

Precious Metals Fall to Start June -- Market Talk

1. Juni 2026, 18:00 UTC

Akquisitionen, Fusionen, Übernahmen

Marsh McLennan Agency Completes Acquisition Of TriBridge Partners >MRSH

1. Juni 2026, 17:18 UTC

Market Talk

Global Asset Managers Accumulate Canadian Government Debt -- Market Talk

1. Juni 2026, 17:18 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1. Juni 2026, 17:10 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Salesforce Estimated to Get $225M Sales Boost From Contentful -- Market Talk

Peer-Vergleich

Kursveränderung

Day One Biopharmaceuticals Inc Prognose

Kursziel

By TipRanks

-3.62% Nachteil

12-Monats-Prognose

Durchschnitt 20.75 USD -3.62%

Hoch 21.5 USD

Tief 17 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Day One Biopharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

7 ratings

Buy

Halten

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Day One Biopharmaceuticals Inc – Dist abgegeben haben.

Stimmung

By Acuity

153 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.